This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Losonsky, G. A. Articles by Levine, M. M. Search for Related Content PubMed PubMed Citation Articles by Losonsky, G. A. Articles by Levine, M. M.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, May 1997, 264-269, Vol 4, No. 3
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Vibriocidal antibody responses in North American volunteers exposed to wild-type or vaccine Vibrio cholerae O139: specificity and relevance to immunity

GA Losonsky, Y Lim, P Motamedi, LE Comstock, JA Johnson, JG Morris Jr, CO Tacket, JB Kaper and MM Levine
Center for Vaccine Development, University of Maryland School of Medicine, and Veterans Affairs Medical Center of Baltimore, 21201, USA.

The emergence of a new agent of cholera, Vibrio cholerae O139, has prompted a reevaluation of the vibriocidal antibody assay. This assay, primarily directed to lipopolysaccharide, is an important correlate of O1 immunity. V. cholerae O139 strains are encapsulated, rendering them relatively resistant to killing by serum. Recent reports suggest that there is strain-to-strain variability in the sensitivity of the vibriocidal assay to fully encapsulated O139 strains. We have assessed a modified vibriocidal assay for fully encapsulated O139 strain AI-1837 and its unencapsulated mutant 2L in sera from 53 volunteers given wild- type AI-1837 or its attenuated derivative CVD 112 and from 48 controls challenged with V. cholerae O1 or strains of the family Enterobacteriaceae. Vibriocidal responses to the AI-1837 and 2L strains were seen in 67 and 89% of volunteers, respectively, following a single exposure to the wild-type strain. However, >50% of all controls had low- level vibriocidal responses to both strains. These nonspecific responses were transient and of the immunoglobulin G isotype. No binding activity against purified O139 lipopolysaccharide (LPS) by immunoblotting was seen in control sera. In contrast, vibriocidal assay and strain 2L LPS responses by immunoblotting were detectable in 91% of tested volunteers following a single exposure to O139. The presence of vibriocidal antibody to AI-1837 or 2L was not associated with protection in rechallenge studies with O139 strain AI-1837. The vibriocidal assay with unencapsulated strain 2L may be used to detect exposure to O139 strain AI-1837 in controlled research trials. However, its lack of specificity does not make it useful for determining exposure to V. cholerae O139 in the field.

This article has been cited by other articles:

• Qadri, F., Svennerholm, A.-M., Shamsuzzaman, S., Bhuiyan, T. R., Harris, J. B., Ghosh, A. N., Nair, G. B., Weintraub, A., Faruque, S. M., Ryan, E. T., Sack, D. A., Calderwood, S. B. (2005). Reduction in Capsular Content and Enhanced Bacterial Susceptibility to Serum Killing of Vibrio cholerae O139 Associated with the 2002 Cholera Epidemic in Bangladesh. Infect. Immun. 73: 6577-6583 [Abstract] [Full Text]  
• Meeks, M. D., Saksena, R., Ma, X., Wade, T. K., Taylor, R. K., Kovac, P., Wade, W. F. (2004). Synthetic Fragments of Vibrio cholerae O1 Inaba O-Specific Polysaccharide Bound to a Protein Carrier Are Immunogenic in Mice but Do Not Induce Protective Antibodies. Infect. Immun. 72: 4090-4101 [Abstract] [Full Text]  
• Attridge, S. R., Johansson, C., Trach, D. D., Qadri, F., Svennerholm, A.-M. (2002). Sensitive Microplate Assay for Detection of Bactericidal Antibodies to Vibrio cholerae O139. CVI 9: 383-387 [Abstract] [Full Text]  
• Kossaczka, Z., Shiloach, J., Johnson, V., Taylor, D. N., Finkelstein, R. A., Robbins, J. B., Szu, S. C. (2000). Vibrio cholerae O139 Conjugate Vaccines: Synthesis and Immunogenicity of V. cholerae O139 Capsular Polysaccharide Conjugates with Recombinant Diphtheria Toxin Mutant in Mice. Infect. Immun. 68: 5037-5043 [Abstract] [Full Text]  
• Attridge, S. R., Qadri, F., Albert, M. J., Manning, P. A. (2000). Susceptibility of Vibrio cholerae O139 to Antibody-Dependent, Complement-Mediated Bacteriolysis. CVI 7: 444-450 [Abstract] [Full Text]  
• Cohen, M. B., Giannella, R. A., Losonsky, G. A., Lang, D. R., Parker, S., Hawkins, J. A., Gunther, C., Schiff, G. A. (1999). Validation and Characterization of a Human Volunteer Challenge Model for Cholera by Using Frozen Bacteria of the New Vibrio cholerae Epidemic Serotype, O139. Infect. Immun. 67: 6346-6349 [Abstract] [Full Text]  
• Tacket, C. O., Taylor, R. K., Losonsky, G., Lim, Y., Nataro, J. P., Kaper, J. B., Levine, M. M. (1998). Investigation of the Roles of Toxin-Coregulated Pili and Mannose-Sensitive Hemagglutinin Pili in the Pathogenesis of Vibrio cholerae O139 Infection. Infect. Immun. 66: 692-695 [Abstract] [Full Text]